Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry-Reference-Cited by-同舟云学术

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry

Published:2018-07 Issue:7 Volume:18 Page:e283-e285
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Gora-Tybor Joanna,Sacha Tomasz,Wącław Joanna,Niesiobędzka-Krężel Joanna,Grzybowska-Izydorczyk Olga,Mędraś Ewa,Dereń-Wagemann Izabela,Patkowska Elżbieta,Seferyńska Ilona,Lewandowski Krzysztof,Wache Anna,Blajer-Olszewska Beata,Wątek Marzena,Kotwica-Mojzych Katarzyna,Wasilewska Ewa,Warzocha Krzysztof,Jamroziak Krzysztof

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Use of real-world claim databases to assess prevalence of comorbid conditions relevant to the treatment of chronic myelogenous leukemia based on National Comprehensive Network treatment guidelines;Jabbour;Clin Lymphoma Myeloma Leuk,2015

2. Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities;Valent;Haematologica,2011

3. Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis;Giles;Leukemia,2013

4. Nilotinib-associated vascular events;Quintás-Cardama;Clin Lymphoma Myeloma Leuk,2012

5. Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis;de Lavallade;Br J Haematol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study;Annals of Hematology;2024-06-11

2. CML in the Very Elderly: The Impact of Comorbidities and TKI Selection in a Real-life Multicenter Study;2024-03-13

3. Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication;Current Hematologic Malignancy Reports;2022-08-06

4. Measuring prognosis in chronic myeloid leukemia: what’s new?;Expert Review of Hematology;2021-06-03

5. How to manage CML patients with comorbidities;Hematology;2020-12-04